Psychotherapeutic Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: P5484A612B04EN
Market Monitor Global

Abstracts

Psychotherapy is a collaborative approach used by psychologists to help people overcome various mental illnesses and emotional difficulties.

This report contains market size and forecasts of Psychotherapeutic Drugs in Global, including the following market information:

Global Psychotherapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Psychotherapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antipsychotic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Psychotherapeutic Drugs include Eli Lilly, Johnson&Johnson, Pfizer, Bristol-Myers Squibb, Allergan, GlaxoSmithKline, AstraZeneca and Astellas Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psychotherapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Psychotherapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Psychotherapeutic Drugs Market Segment Percentages, by Type, 2021 (%)

• Antipsychotic Drugs
• Antidepressants
• Psychotherapeutic Combinations

Global Psychotherapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Psychotherapeutic Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Psychotherapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Psychotherapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Psychotherapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Psychotherapeutic Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Johnson&Johnson
• Pfizer
• Bristol-Myers Squibb
• Allergan
• GlaxoSmithKline
• AstraZeneca
• Astellas Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Psychotherapeutic Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Psychotherapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PSYCHOTHERAPEUTIC DRUGS OVERALL MARKET SIZE

2.1 Global Psychotherapeutic Drugs Market Size: 2021 VS 2028
2.2 Global Psychotherapeutic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Psychotherapeutic Drugs Players in Global Market
3.2 Top Global Psychotherapeutic Drugs Companies Ranked by Revenue
3.3 Global Psychotherapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psychotherapeutic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Psychotherapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psychotherapeutic Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Psychotherapeutic Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Psychotherapeutic Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Psychotherapeutic Drugs Market Size Markets, 2021 & 2028
  4.1.2 Antipsychotic Drugs
  4.1.3 Antidepressants
  4.1.4 Psychotherapeutic Combinations
4.2 By Type - Global Psychotherapeutic Drugs Revenue & Forecasts
  4.2.1 By Type - Global Psychotherapeutic Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Psychotherapeutic Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Psychotherapeutic Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Psychotherapeutic Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Psychotherapeutic Drugs Revenue & Forecasts
  5.2.1 By Application - Global Psychotherapeutic Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Psychotherapeutic Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Psychotherapeutic Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Psychotherapeutic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Psychotherapeutic Drugs Revenue & Forecasts
  6.2.1 By Region - Global Psychotherapeutic Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Psychotherapeutic Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Psychotherapeutic Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Psychotherapeutic Drugs Revenue, 2017-2028
  6.3.2 US Psychotherapeutic Drugs Market Size, 2017-2028
  6.3.3 Canada Psychotherapeutic Drugs Market Size, 2017-2028
  6.3.4 Mexico Psychotherapeutic Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Psychotherapeutic Drugs Revenue, 2017-2028
  6.4.2 Germany Psychotherapeutic Drugs Market Size, 2017-2028
  6.4.3 France Psychotherapeutic Drugs Market Size, 2017-2028
  6.4.4 U.K. Psychotherapeutic Drugs Market Size, 2017-2028
  6.4.5 Italy Psychotherapeutic Drugs Market Size, 2017-2028
  6.4.6 Russia Psychotherapeutic Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Psychotherapeutic Drugs Market Size, 2017-2028
  6.4.8 Benelux Psychotherapeutic Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Psychotherapeutic Drugs Revenue, 2017-2028
  6.5.2 China Psychotherapeutic Drugs Market Size, 2017-2028
  6.5.3 Japan Psychotherapeutic Drugs Market Size, 2017-2028
  6.5.4 South Korea Psychotherapeutic Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Psychotherapeutic Drugs Market Size, 2017-2028
  6.5.6 India Psychotherapeutic Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Psychotherapeutic Drugs Revenue, 2017-2028
  6.6.2 Brazil Psychotherapeutic Drugs Market Size, 2017-2028
  6.6.3 Argentina Psychotherapeutic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Psychotherapeutic Drugs Revenue, 2017-2028
  6.7.2 Turkey Psychotherapeutic Drugs Market Size, 2017-2028
  6.7.3 Israel Psychotherapeutic Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Psychotherapeutic Drugs Market Size, 2017-2028
  6.7.5 UAE Psychotherapeutic Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Psychotherapeutic Drugs Major Product Offerings
  7.1.4 Eli Lilly Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Johnson&Johnson
  7.2.1 Johnson&Johnson Corporate Summary
  7.2.2 Johnson&Johnson Business Overview
  7.2.3 Johnson&Johnson Psychotherapeutic Drugs Major Product Offerings
  7.2.4 Johnson&Johnson Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.2.5 Johnson&Johnson Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Psychotherapeutic Drugs Major Product Offerings
  7.3.4 Pfizer Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Psychotherapeutic Drugs Major Product Offerings
  7.4.4 Bristol-Myers Squibb Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Allergan
  7.5.1 Allergan Corporate Summary
  7.5.2 Allergan Business Overview
  7.5.3 Allergan Psychotherapeutic Drugs Major Product Offerings
  7.5.4 Allergan Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.5.5 Allergan Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Psychotherapeutic Drugs Major Product Offerings
  7.6.4 GlaxoSmithKline Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Psychotherapeutic Drugs Major Product Offerings
  7.7.4 AstraZeneca Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Astellas Pharma
  7.8.1 Astellas Pharma Corporate Summary
  7.8.2 Astellas Pharma Business Overview
  7.8.3 Astellas Pharma Psychotherapeutic Drugs Major Product Offerings
  7.8.4 Astellas Pharma Psychotherapeutic Drugs Revenue in Global Market (2017-2022)
  7.8.5 Astellas Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Psychotherapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Psychotherapeutic Drugs Market Drivers in Global Market
Table 3. Psychotherapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Psychotherapeutic Drugs in Global Market
Table 5. Top Psychotherapeutic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Psychotherapeutic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Psychotherapeutic Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Psychotherapeutic Drugs Product Type
Table 9. List of Global Tier 1 Psychotherapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychotherapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Psychotherapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Psychotherapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Psychotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Psychotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Psychotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Psychotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Psychotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Psychotherapeutic Drugs Product Offerings
Table 32. Eli Lilly Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Johnson&Johnson Corporate Summary
Table 34. Johnson&Johnson Psychotherapeutic Drugs Product Offerings
Table 35. Johnson&Johnson Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Psychotherapeutic Drugs Product Offerings
Table 38. Pfizer Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Psychotherapeutic Drugs Product Offerings
Table 41. Bristol-Myers Squibb Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Psychotherapeutic Drugs Product Offerings
Table 44. Allergan Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Psychotherapeutic Drugs Product Offerings
Table 47. GlaxoSmithKline Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Psychotherapeutic Drugs Product Offerings
Table 50. AstraZeneca Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Astellas Pharma Corporate Summary
Table 52. Astellas Pharma Psychotherapeutic Drugs Product Offerings
Table 53. Astellas Pharma Psychotherapeutic Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Psychotherapeutic Drugs Segment by Type in 2021
Figure 2. Psychotherapeutic Drugs Segment by Application in 2021
Figure 3. Global Psychotherapeutic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Psychotherapeutic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Psychotherapeutic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psychotherapeutic Drugs Revenue in 2021
Figure 8. By Type - Global Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 12. US Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 24. China Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Psychotherapeutic Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Psychotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson&Johnson Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Astellas Pharma Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)